News | Digital Pathology | August 15, 2019

Push for Personalized Medicine Driving Whole Slide Imaging System Growth

Market research report predicts early adoption of new technologies in North America and Europe will strengthen digital pathology market

Push for Personalized Medicine Driving Whole Slide Imaging System Growth

August 15, 2019 — Research on personalized medicines is gaining popularity in the cancer research industry, which has increased the need for effective and reliable diagnostic procedures and is expected to drive the growth of the whole slide imaging systems market. Growing demand for laboratory diagnosis procedures is also expected to fuel future growth, according to a new report from Persistence Market Research.

Whole slide imaging systems are scanners used to view sample pathology slides effectively. Some of the systems are small and are used to view a single slide sample, whereas some scanners are big and give an image of 100 slide samples simultaneously. Whole slide imaging systems consists of a microscope, light source, computer and a camera attached to it. The light source can be a bright light source or a fluorescent light source. The system is also incorporated with a software that is used to manipulate the slide view. The camera captures the slide image, which can be viewed on the computer screen.

The whole slide imaging systems market is in the growth phase as a large number of companies are currently focusing on mergers and acquisitions. Tele-pathology is gaining popularity due to the feature of remote sharing of the slides as compared to other conventional slide sharing practices. Growing research & development activities in cancer treatment and personalized medicines is expected to provide prominent growth opportunities for the whole slide imaging systems market.

The pathology industry has witnessed significant transition in terms of sample imaging, according to the Persistence Market Research report. Presently, whole slide imaging is reasonably dominant in the research and development sector. Increase in R&D activities is also projected to fuel the growth of the whole slide imaging systems market. Likewise, commercialization of multipurpose instruments with cloud-enabled technologies is also expected to drive market growth.

The high cost of whole slide imaging systems, plus high maintenance and installations costs, are the prime factors projected to hamper adoption across resource-poor countries. The report notes that the whole slide imaging systems market is marginally regulated through commercial guidelines, which can lead to lack of clarity about the samples to be viewed. Lack of awareness about digital pathology is also expected to limit market growth.

The report offers a comprehensive taxonomy of whole slide imaging systems based on product type, end user and region. Based on product type, the market is segmented into bright field scanners and fluorescent scanners. Further analysis by product type reveals the slide imaging systems segment accounted for 65 percent of the global whole slide imaging systems market in 2017. Based on end users, the market is segmented into hospitals, diagnostic laboratories and research laboratories. 

The whole slide imaging systems market has been analyzed across regions of North America, Europe, Latin America, Asia Pacific excluding Japan (APEJ), Japan and MEA. North America is projected to be the dominant regional market due to increasing need for reliable and real-time pathology solutions for offshore research activities in the healthcare sector. North America and Europe are expected to hold three-quarters share of the global whole slide imaging systems market, owing to early adoption of novel technologies in these regions.

Read the full report here.

For more information: www.persistencemarketresearch.com

Related Content

VIDEO: Integrating Digital Pathology With Radiology

Related Content

Xifin Launches Version 6 of Laboratory Information System
News | Digital Pathology | September 05, 2019
Xifin announced the launch of the next evolution of its laboratory information system (LIS), Xifin LIS 6. The expanded...
Philips Signs Agreement to Create Taiwan's First Fully Digitalized Pathology Department
News | Digital Pathology | August 23, 2019
Philips announced that Taipei Veterans General Hospital (TPVGH) will utilize the Philips IntelliSite Pathology Solution...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
Sectra Providing Centralized Regional Solution for Digital Pathology in the U.K.
News | Digital Pathology | June 14, 2019
Sectra has signed a five-year contract with North Tees and Hartlepool National Health System (NHS) Foundation Trust for...
Leica Biosystems Receives FDA Clearance for Aperio AT2 DX Digital Pathology System
Technology | Digital Pathology | May 29, 2019
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX...
Alverno Laboratories Implementing Philips IntelliSite Pathology Solution
News | Digital Pathology | May 28, 2019
Philips and Alverno Laboratories, a provider of high-quality diagnostic testing services, announced that Alverno will...
Deep Lens Closes Series A Financing for Digital AI Pathology Platform
News | Digital Pathology | April 09, 2019
Digital pathology company Deep Lens Inc. announced the closing of a $14 million Series A financing that will further...
FDA Grants Breakthrough Designation to Paige.AI
News | Digital Pathology | March 08, 2019
Artificial intelligence (AI) startup company Paige.AI has been granted Breakthrough Device designation by the U.S. Food...